225 related articles for article (PubMed ID: 32579890)
1. Targeting drug delivery in the vascular system: Focus on endothelium.
Glassman PM; Myerson JW; Ferguson LT; Kiseleva RY; Shuvaev VV; Brenner JS; Muzykantov VR
Adv Drug Deliv Rev; 2020; 157():96-117. PubMed ID: 32579890
[TBL] [Abstract][Full Text] [Related]
2. Vascular targeting of nanocarriers: perplexing aspects of the seemingly straightforward paradigm.
Howard M; Zern BJ; Anselmo AC; Shuvaev VV; Mitragotri S; Muzykantov V
ACS Nano; 2014 May; 8(5):4100-32. PubMed ID: 24787360
[TBL] [Abstract][Full Text] [Related]
3. Targeted endothelial nanomedicine for common acute pathological conditions.
Shuvaev VV; Brenner JS; Muzykantov VR
J Control Release; 2015 Dec; 219():576-595. PubMed ID: 26435455
[TBL] [Abstract][Full Text] [Related]
4. Targeting vascular inflammation through emerging methods and drug carriers.
Nong J; Glassman PM; Muzykantov VR
Adv Drug Deliv Rev; 2022 May; 184():114180. PubMed ID: 35271986
[TBL] [Abstract][Full Text] [Related]
5. Dynamic factors controlling targeting nanocarriers to vascular endothelium.
Muzykantov VR; Radhakrishnan R; Eckmann DM
Curr Drug Metab; 2012 Jan; 13(1):70-81. PubMed ID: 22292809
[TBL] [Abstract][Full Text] [Related]
6. Dynamic and cellular interactions of nanoparticles in vascular-targeted drug delivery.
Huang RB; Mocherla S; Heslinga MJ; Charoenphol P; Eniola-Adefeso O
Mol Membr Biol; 2010 Oct; 27(7):312-27. PubMed ID: 21028938
[TBL] [Abstract][Full Text] [Related]
7. Advanced drug delivery systems that target the vascular endothelium.
Ding BS; Dziubla T; Shuvaev VV; Muro S; Muzykantov VR
Mol Interv; 2006 Apr; 6(2):98-112. PubMed ID: 16565472
[TBL] [Abstract][Full Text] [Related]
8. Nanocarriers for vascular delivery of anti-inflammatory agents.
Howard MD; Hood ED; Zern B; Shuvaev VV; Grosser T; Muzykantov VR
Annu Rev Pharmacol Toxicol; 2014; 54():205-26. PubMed ID: 24392694
[TBL] [Abstract][Full Text] [Related]
9. Fundamentals, challenges, and nanomedicine-based solutions for ocular diseases.
Srinivasarao DA; Lohiya G; Katti DS
Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2019 Jul; 11(4):e1548. PubMed ID: 30506871
[TBL] [Abstract][Full Text] [Related]
10. Leveraging molecular heterogeneity of the vascular endothelium for targeted drug delivery and imaging.
Pasqualini R; Moeller BJ; Arap W
Semin Thromb Hemost; 2010 Apr; 36(3):343-51. PubMed ID: 20490984
[TBL] [Abstract][Full Text] [Related]
11. The role of the cell surface glycocalyx in drug delivery to and through the endothelium.
Fu L; Kim HN; Sterling JD; Baker SM; Lord MS
Adv Drug Deliv Rev; 2022 May; 184():114195. PubMed ID: 35292326
[TBL] [Abstract][Full Text] [Related]
12. Therapeutic targets for endothelial dysfunction in vascular diseases.
Huynh DTN; Heo KS
Arch Pharm Res; 2019 Oct; 42(10):848-861. PubMed ID: 31420777
[TBL] [Abstract][Full Text] [Related]
13. Advanced nanomedicines for the treatment of inflammatory diseases.
Brusini R; Varna M; Couvreur P
Adv Drug Deliv Rev; 2020; 157():161-178. PubMed ID: 32697950
[TBL] [Abstract][Full Text] [Related]
14. Cellular and Molecular Targeted Drug Delivery in Central Nervous System Cancers: Advances in Targeting Strategies.
Zhao X; Ye Y; Ge S; Sun P; Yu P
Curr Top Med Chem; 2020; 20(30):2762-2776. PubMed ID: 32851962
[TBL] [Abstract][Full Text] [Related]
15. Brain endothelial cells as pharmacological targets in brain tumors.
Demeule M; Régina A; Annabi B; Bertrand Y; Bojanowski MW; Béliveau R
Mol Neurobiol; 2004 Oct; 30(2):157-83. PubMed ID: 15475625
[TBL] [Abstract][Full Text] [Related]
16. Vascular targeting: recent advances and therapeutic perspectives.
Hajitou A; Pasqualini R; Arap W
Trends Cardiovasc Med; 2006 Apr; 16(3):80-8. PubMed ID: 16546688
[TBL] [Abstract][Full Text] [Related]
17. Advances in an active and passive targeting to tumor and adipose tissues.
Sakurai Y; Kajimoto K; Hatakeyama H; Harashima H
Expert Opin Drug Deliv; 2015 Jan; 12(1):41-52. PubMed ID: 25376864
[TBL] [Abstract][Full Text] [Related]
18. Endothelial endocytic pathways: gates for vascular drug delivery.
Muro S; Koval M; Muzykantov V
Curr Vasc Pharmacol; 2004 Jul; 2(3):281-99. PubMed ID: 15320826
[TBL] [Abstract][Full Text] [Related]
19. Surmounting the endothelial barrier for delivery of drugs and imaging tracers.
Schnitzler JG; Dzobo KE; Nurmohamed NS; Stroes ESG; Kroon J
Atherosclerosis; 2020 Dec; 315():93-101. PubMed ID: 32444105
[TBL] [Abstract][Full Text] [Related]
20. Anti-angiogenic nanotherapy via active targeting systems to tumors and adipose tissue vasculature.
Sakurai Y; Kajimoto K; Harashima H
Biomater Sci; 2015 Sep; 3(9):1253-65. PubMed ID: 26261854
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
